CURE icon

Direxion Daily Healthcare Bull 3X Shares

80.75 USD
-1.31
1.60%
At close Jun 13, 4:00 PM EDT
After hours
81.00
+0.25
0.31%
1 day
-1.60%
5 days
3.63%
1 month
7.90%
3 months
-20.74%
6 months
-18.34%
Year to date
-12.28%
1 year
-30.93%
5 years
60.03%
10 years
106.84%
0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

75% more call options, than puts

Call options by funds: $7.19M | Put options by funds: $4.1M

0.76% less ownership

Funds ownership: 9.0% [Q4 2024] → 8.24% (-0.76%) [Q1 2025]

9% less funds holding

Funds holding: 22 [Q4 2024] → 20 (-2) [Q1 2025]

15% less capital invested

Capital invested by funds: $15M [Q4 2024] → $12.7M (-$2.22M) [Q1 2025]

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Research analyst outlook

We haven’t received any recent analyst ratings for CURE.

Financial journalist opinion

Neutral
Seeking Alpha
1 week ago
CURE: A Useful Speculative Tool But Not An Investing Hold
CURE is designed for daily 3x leveraged exposure to the healthcare sector, making it suitable for short-term speculation or hedging, not long-term investment. Daily resets and derivatives costs cause value decay over time, so holding CURE for months or years leads to underperformance versus the underlying index. CURE is effective for tactical trades or hedges on short-term healthcare sector moves, but not for buy-and-hold strategies.
CURE: A Useful Speculative Tool But Not An Investing Hold
Positive
ETF Trends
3 months ago
2 Sectors to Trade as Equity Funds See Higher Inflows
Sometimes traders can set up a potential plays when they see where investor money is flowing. This is available with fund inflows, which saw technology and healthcare equities gain a lion's share of February's flows.
2 Sectors to Trade as Equity Funds See Higher Inflows
Positive
Zacks Investment Research
3 months ago
5 Leveraged ETFs With Double-Digit Gains Halfway Through Q1
We highlight a bunch of the best-performing leveraged equity ETFs halfway through the first quarter.
5 Leveraged ETFs With Double-Digit Gains Halfway Through Q1
Positive
ETF Trends
3 months ago
Rising Number of Flu Cases Could Elevate These ETFs
Cases of the flu have reached elevated levels as of late. This could keep healthcare stocks and ETFs with a healthcare focus on the radar for traders.
Rising Number of Flu Cases Could Elevate These ETFs
Positive
Zacks Investment Research
4 months ago
5 Leveraged ETFs That Witnessed Double-Digit Gains in January
We highlight a bunch of the best-performing leveraged equity ETFs of January.
5 Leveraged ETFs That Witnessed Double-Digit Gains in January
Positive
Seeking Alpha
5 months ago
CURE: Analyst Estimates Point To Significant Gains In 2025
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks. Since October 2024 the forward P/E ratio for CURE's largest holdings has marginally increased. Even so Wall Street analysts predict a weighted average gain of 21% for CURE's top ten components over the next 12 months.
CURE: Analyst Estimates Point To Significant Gains In 2025
Neutral
ETF Trends
6 months ago
There Could Be Value in Healthcare Stocks Ahead of 2025
When a new presidential administration is set to take office, there's uncertainty as to whether specific sectors could be impacted. In the case of healthcare, that's certainly the case, especially in biotech.
There Could Be Value in Healthcare Stocks Ahead of 2025
Positive
Seeking Alpha
8 months ago
CURE: A Leveraged ETF To Own Throughout This Century
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% of the performance of an index heavily concentrated in large-capitalization US healthcare stocks. CURE's top ten holdings trade at a weighted average forward P/E of 28.27, with analysts predicting a 9.78% gain over the next 12 months. The healthcare sector benefits from long-term trends such as an aging population and an increased focus on longevity. Artificial intelligence will also help in developing new treatments.
CURE: A Leveraged ETF To Own Throughout This Century
Positive
Zacks Investment Research
9 months ago
5 Leveraged ETFs With Double-Digit Gains in August
After witnessing steep sell-offs at the start of August, all three major indices end the month with double-digit gains.
5 Leveraged ETFs With Double-Digit Gains in August
Positive
ETF Trends
10 months ago
Q2 Earnings Season Looms Large in Hopes for Broader Stocks Rally
Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.
Q2 Earnings Season Looms Large in Hopes for Broader Stocks Rally
Charts implemented using Lightweight Charts™